This an example of a cross-over study where 7 smokeless tobacco products were tested. Subject used the product ad libitum and then the next day the product was evaluated as specified in the protocol in the morning.
$titleHtml
ex.xpt
Row
STUDYID
DOMAIN
USUBJID
EXSEQ
EXTRT
EXCAT
EXDOSE
EXDOSU
EXDOSFRM
EXROUTE
EXPSTRG
EXPSTRGU
VISITNUM
VISIT
VISITDY
EPOCH
EXSTDTC
EXENDTC
1
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
1
PRODUCT C
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
6
mg
10
DAY -1
-1
TREATMENT
2019-06-27T13:10:33
2019-06-27T13:38:49
2
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
2
PRODUCT C
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
6
mg
10
DAY -1
-1
TREATMENT
2019-06-27T14:29:13
2019-06-27T14:54:53
3
ALCS-REG-STUDY
EXC
ALCS-REG-STUDY_10001
3
PRODUCT C
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
6
mg
11
DAY 1
1
TREATMENT
2019-06-28T08:00:12
2019-06-28T08:30:21
4
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
4
PRODUCT E
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
4
mg
11
DAY 1
1
TREATMENT
2019-06-28T14:01:52
2019-06-28T14:55:27
5
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
5
PRODUCT E
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
4
mg
11
DAY 1
1
TREATMENT
2019-06-28T15:18:35
2019-06-28T15:57:33
6
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
6
PRODUCT E
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
4
mg
12
DAY 2
2
TREATMENT
2019-06-29T08:00:08
2019-06-29T08:30:13
7
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
7
PRODUCT B
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
12
DAY 2
2
TREATMENT
2019-06-29T14:01:50
2019-06-29T14:50:11
8
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
8
PRODUCT B
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
12
DAY 2
2
TREATMENT
2019-06-29T15:24:33
2019-06-29T15:59:46
9
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
9
PRODUCT B
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
13
DAY 3
3
TREATMENT
2019-06-30T08:00:00
2019-06-30T08:30:00
10
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
10
PRODUCT D
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
6
mg
13
DAY 3
3
TREATMENT
2019-06-30T14:12:32
2019-06-30T14:47:47
11
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
11
PRODUCT D
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
6
mg
13
DAY 3
3
TREATMENT
2019-06-30T15:24:46
2019-06-30T16:04:57
12
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
12
PRODUCT D
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
6
mg
14
DAY 4
4
TREATMENT
2019-07-01T08:00:00
2019-07-01T08:30:00
13
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
13
PRODUCT A
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
8
mg
14
DAY 4
4
TREATMENT
2019-07-01T14:02:36
2019-07-01T14:47:33
14
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
14
PRODUCT A
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
8
mg
14
DAY 4
4
TREATMENT
2019-07-01T15:37:45
2019-07-01T15:58:15
15
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
15
PRODUCT A
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
8
mg
15
DAY 5
5
TREATMENT
2019-07-02T08:00:00
2019-07-02T08:30:01
16
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
16
PRODUCT F
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
15
DAY 5
5
TREATMENT
2019-07-02T14:11:00
2019-07-02T14:54:08
17
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
17
PRODUCT F
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
15
DAY 5
5
TREATMENT
2019-07-02T15:38:52
2019-07-02T15:59:50
18
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
18
PRODUCT F
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
16
DAY 6
6
TREATMENT
2019-07-03T08:00:00
2019-07-03T08:30:00
19
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
19
PRODUCT G
UNCONTROLLED PRODUCT USE
3.37
g
QUID
ORAL
4
mg
16
DAY 6
6
TREATMENT
2019-07-03T14:13:14
2019-07-03T14:57:40
20
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
20
PRODUCT G
UNCONTROLLED PRODUCT USE
3.2
g
QUID
ORAL
4
mg
16
DAY 6
6
TREATMENT
2019-07-03T15:35:01
2019-07-03T16:07:25
21
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10001
21
PRODUCT G
CONTROLLED PRODUCT USE
2
g
QUID
ORAL
4
mg
17
DAY 7/EARLY TERMINATION
7
TREATMENT
2019-07-04T08:00:04
2019-07-04T08:30:05
22
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
1
PRODUCT E
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
8
mg
10
DAY -1
-1
TREATMENT
2019-07-04T14:06:09
2019-07-04T14:14:14
23
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
2
PRODUCT E
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
8
mg
11
DAY 1
1
TREATMENT
2019-07-05T08:00:00
2019-07-05T08:30:00
24
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
3
PRODUCT D
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
4
mg
11
DAY 1
1
TREATMENT
2019-07-05T14:02:39
2019-07-05T14:18:57
25
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
4
PRODUCT D
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
4
mg
12
DAY 2
2
TREATMENT
2019-07-06T08:00:00
2019-07-06T08:30:00
26
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
5
PRODUCT C
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
6
mg
12
DAY 2
2
TREATMENT
2019-07-06T14:00:00
2019-07-06T14:08:40
27
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
6
PRODUCT C
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
6
mg
12
DAY 2
2
TREATMENT
2019-07-06T15:52:53
2019-07-06T15:59:21
28
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
7
PRODUCT C
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
6
mg
13
DAY 3
3
TREATMENT
2019-07-07T08:00:00
2019-07-07T08:30:00
29
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
8
PRODUCT F
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
13
DAY 3
3
TREATMENT
2019-07-07T14:01:12
2019-07-07T14:12:25
30
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
9
PRODUCT F
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
13
DAY 3
3
TREATMENT
2019-07-07T14:57:49
2019-07-07T15:07:07
31
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
10
PRODUCT F
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
14
DAY 4
4
TREATMENT
2019-07-08T08:00:00
2019-07-08T08:30:00
32
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
11
PRODUCT B
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
14
DAY 4
4
TREATMENT
2019-07-08T14:00:52
2019-07-08T14:17:31
33
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
12
PRODUCT B
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
14
DAY 4
4
TREATMENT
2019-07-08T14:46:07
2019-07-08T14:53:43
34
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
13
PRODUCT B
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
2
mg
15
DAY 5
5
TREATMENT
2019-07-09T08:00:01
2019-07-09T08:30:01
35
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
14
PRODUCT G
UNCONTROLLED PRODUCT USE
2.69
g
QUID
ORAL
4
mg
15
DAY 5
5
TREATMENT
2019-07-09T14:06:24
2019-07-09T14:30:16
36
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
15
PRODUCT G
UNCONTROLLED PRODUCT USE
3.3
g
QUID
ORAL
4
mg
15
DAY 5
5
TREATMENT
2019-07-09T14:49:39
2019-07-09T15:15:16
37
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
16
PRODUCT G
CONTROLLED PRODUCT USE
2
g
QUID
ORAL
4
mg
16
DAY 6
6
TREATMENT
2019-07-10T08:00:00
2019-07-10T08:30:00
38
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
17
PRODUCT A
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
8
mg
16
DAY 6
6
TREATMENT
2019-07-10T14:02:07
2019-07-10T14:35:40
39
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
18
PRODUCT A
UNCONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
8
mg
16
DAY 6
6
TREATMENT
2019-07-10T15:27:37
2019-07-10T15:58:24
40
ALCS-REG-STUDY
EX
ALCS-REG-STUDY_10002
19
PRODUCT A
CONTROLLED PRODUCT USE
1
POUCH
POUCH
ORAL
8
mg
17
DAY 7/EARLY TERMINATION
7
TREATMENT
2019-07-11T08:00:00
2019-07-11T08:30:00
Dataset Debug Messages
There are 22 leading, trailing, or non-breaking spaces in the dataset.
There seem to be multiple domains (EX, EXC) present in the dataset.